Skip to content

To study the effect of upakunchika (Nigella sativa) powder in scanty menses.

Single arm open labelled randomized experimental study to evaluate the efficacy of Upakunchika churna(Nigella sativa) in alpartava(hypomenorrhea).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040118
Enrollment
60
Registered
2022-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Sponsors

DrKamala lakshmi Ranganathan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married or unmarried female patients from 18 to 35 years of age. Patients with hypomenorrhea.

Exclusion criteria

Exclusion criteria: Patients taking Oral contraceptives . Patients with complex cysts or malignancy.

Design outcomes

Primary

MeasureTime frame
Improvement in the quantity of menstrual bleeding.(from hypomenorrhea)Timepoint: Monthly evaluation upto 3 months of treatment period.

Secondary

MeasureTime frame
Improvement in ovulation (from oligo ovulation)Timepoint: Evaluation before treatment and after 3 months of treatment.

Countries

India

Contacts

Public ContactDrJayashri Patil

Dr.D.Y.Patil college of ayurved and research centre

jayupa.patil6@gmail.com9921244690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026